Schulz_2009_Anticancer.Drugs_20_867

Reference

Title : UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy? - Schulz_2009_Anticancer.Drugs_20_867
Author(s) : Schulz C , Boeck S , Heinemann V , Stemmler HJ
Ref : Anticancer Drugs , 20 :867 , 2009
Abstract : Schulz_2009_Anticancer.Drugs_20_867
ESTHER : Schulz_2009_Anticancer.Drugs_20_867
PubMedSearch : Schulz_2009_Anticancer.Drugs_20_867
PubMedID: 19770637

Related information

Citations formats

Schulz C, Boeck S, Heinemann V, Stemmler HJ (2009)
UGT1A1 genotyping: a predictor of irinotecan-associated side effects and drug efficacy?
Anticancer Drugs 20 :867

Schulz C, Boeck S, Heinemann V, Stemmler HJ (2009)
Anticancer Drugs 20 :867